MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$59.11
-4.63%
Mkt Cap $2.91B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$71.50
Range $56.00 – $90.00
Implied Upside
+21.0%
Consensus $71.50 vs current $59.11